Evidence for an impaired long-chain fatty acid oxidation and ketogenesis in Fao hepatoma cells.
Fatty acid metabolism has been studied in Fao rat hepatoma cells. In basal conditions of culture, [1-14C]oleate is mainly esterified (85% of oleate uptake) in Fao cells, phospholipids being the most important esterified products (60% of oleate esterified). Addition of N6,O2'-dibutyryl-adenosine 3',5'-monophosphate (0.1 mM) in Fao cells does not change the metabolic fate of oleate whereas it induces gluconeogenesis and phosphoenolpyruvate carboxykinase mRNA accumulation. It is shown that the limitation of oleate oxidation is located at the level of the entry into mitochondria since octanoate is actively oxidized in Fao cells. Neither the activities of carnitine palmitoyltransferase (CPT) I and II nor the CPT II protein amount are affected by cAMP addition. The limitation of oleate oxidation in Fao cells results from (a) a high rate of lipogenesis and a high malonyl-CoA concentration, (b) a CPT I very sensitive to malonyl-CoA inhibition. The presence of an active oleate oxidation in mitochondria isolated from Fao cells confirms that CPT I is the limiting step of oleate oxidation. Moreover, Fao cells are unable to perform ketogenesis. This particular feature results from a specific deficiency in mitochondrial hydroxymethylglutaryl-CoA synthase protein, activity and gene expression. The metabolic characteristics observed in Fao cells could be a common feature in hepatoma cell lines with regard to the low capacity for long-chain fatty acid oxidation and ketone body production observed in the rat H4IIE and the human HepG2 cells.
Centre de Recherche sur l'Endocrinologie Moléculaire et le Développement, Meudon-Bellevue, France.
C
C
Prip-Buus
A C
AC
Bouthillier-Voisin
C
C
Kohl
F
F
Demaugre
J
J
Girard
J P
JP
Pegorier
D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002210:Caprylates / Q000378:metabolism; D002334:Carnitine O-Palmitoyltransferase / Q000378:metabolism; D004951:Esterification; D005227:Fatty Acids / Q000378:metabolism*; D006801:Humans; D006904:Hydroxymethylglutaryl-CoA Synthase / Q000378:metabolism; D007657:Ketone Bodies / Q000096:biosynthesis*; D007700:Kinetics; D008055:Lipids / Q000096:biosynthesis; D008114:Liver Neoplasms, Experimental / Q000378:metabolism*; D008297:Male; D008316:Malonyl Coenzyme A / Q000378:metabolism; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism; D019301:Oleic Acid; D009829:Oleic Acids / Q000378:metabolism; D010084:Oxidation-Reduction; D051381:Rats; D017208:Rats, Wistar; D014407:Tumor Cells, Cultured
D002210:Caprylates; D005227:Fatty Acids; D007657:Ketone Bodies; D008055:Lipids; D009829:Oleic Acids; D019301:Oleic Acid; D008316:Malonyl Coenzyme A; D003994:Bucladesine; D002334:Carnitine O-Palmitoyltransferase; D006904:Hydroxymethylglutaryl-CoA Synthase; C031492:octanoic acid